Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

EUSA’s Fotivda approved for NHS use in Scotland. Specialist pharma company EUSA Pharma has welcomed the Scottish Medicines Consortium approval of its renal cell carcinoma treatment Fotivda (tivozanib). ... year to access this treatment through the NHS

Latest news

More from news
Approximately 1 fully matching, plus 196 partially matching documents found.

Latest Intelligence

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    It means we have to think big in designing programmes. We must understand how we can affect the system and improve decision-making, information, access, monitoring and treatment transitions. ... making, information, access, monitoring and treatment

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Simplifying HCP access to digital information. New industry-standards group launched. The life science industry’s commercial model has transformed significantly over the past decade. ... This new standard will improve how life science companies

  • The gold standard of scientific evidence The gold standard of scientific evidence

    By randomising access to the treatment, researchers would be able to measure efficacy using robust statistical methods. ... Even social media data can be used to measure real-world treatment safety and effectiveness.

  • The real-world data conundrum The real-world data conundrum

    treatment options, access for populations in developing countries and an up-to-date evidence-base is ever increasing. ... when healthcare professionals will be able to provide the right treatment, for the right person, at the right dose, at the right time

More from intelligence
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics